Mastering Cryosurgical Ablation for Bone Tumors: An Intraoperative Guide

Introduction and Historical Context

Cryoablation is a potent surgical adjuvant utilized in orthopedic oncology to induce targeted, in situ cellular necrosis. When applied to the management of bone tumors, the direct pour of liquid nitrogen or the use of closed argon-gas systems serves as a highly effective adjunct to intralesional curettage. This approach allows for the eradication of microscopic residual disease in a wide variety of benign aggressive, primary low-grade malignant, and metastatic bone lesions. By extending the surgical margin chemically and thermally rather than anatomically, cryoablation facilitates joint preservation and obviates the severe functional morbidity associated with wide en bloc resection.

The conceptual framework for orthopedic cryoablation was established in 1966 by Gage et al., who utilized a canine model to demonstrate that perfusing liquid nitrogen (boiling point: -196°C) through encircling latex coils induced a 2-cm rim of circumferential bone necrosis. Radiographic and histopathologic analyses confirmed that this profound thermal insult resulted in mechanical weakening and spontaneous fracture, which was subsequently followed by creeping substitution and new bone formation originating from the vital periphery. Translating these findings to human pathology, Marcove and Miller first reported the clinical application of intralesional cryoablation in 1969, successfully utilizing a direct liquid nitrogen pour following the curettage of a metastatic lesion to achieve tumor necrosis while sparing the patient an amputation.

Pathophysiology and Mechanisms of Tissue Necrosis

The induction of cellular death via cryoablation is not a singular event but a complex cascade of immediate and delayed physiological disruptions. Experimental models indicate that absolute temperatures between -21°C and -60°C are required to guarantee cellular necrosis; temperatures dropping below -60°C do not confer additional lethality but do increase the depth of the necrotic margin.

Immediate Cytotoxicity

The immediate cytotoxic effects of extreme cold are driven by four primary mechanisms:
1. Intracellular Ice Crystal Formation: The most lethal component of cryoablation. Rapid freezing, such as that achieved by the direct pour of liquid nitrogen, prevents the osmotic egress of water from the cell, leading to instantaneous intracellular crystallization and catastrophic mechanical disruption of the cell membrane and organelles.
2. Thermal Shock: Rapid temperature drops disrupt lipid bilayers and destabilize cellular architecture.
3. Osmotic Dehydration: During slower freezing phases, extracellular ice forms first, creating a hyperosmotic extracellular environment that draws water out of the cell, leading to severe cellular dehydration and toxic intracellular electrolyte concentrations.
4. Protein Denaturation: Extreme cold and electrolyte shifts irreversibly denature structural and enzymatic proteins.

Delayed Necrosis and Microvascular Stasis

Following the immediate thermal insult, a secondary wave of delayed, progressive necrosis occurs due to profound microvascular injury. Cryoablation induces endothelial damage, leading to increased capillary permeability, edema, and subsequent platelet aggregation. This culminates in widespread microvascular thrombosis and ischemic necrosis of the surrounding tissue rim. Histologically, the bone marrow exhibits a 1- to 2-cm rim of coagulative necrosis with minimal acute inflammatory response, eventually undergoing liquefaction, progressive fibrosis, and the appearance of large, thrombosed vessels.

The Freeze-Thaw Cycle

The physical parameters of the freeze-thaw cycle dictate the extent of tumor kill. A rapid freeze maximizes intracellular ice formation, while a slow, spontaneous thaw induces intracellular recrystallization, causing further membrane shearing. Furthermore, repeated freeze-thaw cycles exponentially increase tissue necrosis because the initial cycle destroys local microcirculation, effectively eliminating the "heat sink" effect of flowing blood and improving the thermal conductivity of the tissue for subsequent cycles.

Indications and Patient Selection

Appropriate patient and lesion selection is paramount to balancing oncologic efficacy with structural preservation.

Histologic Indications

Cryoablation is indicated as an adjuvant to curettage for:
* Benign Aggressive Tumors: Giant cell tumor of bone (GCT), aneurysmal bone cyst (ABC), chondroblastoma, osteoblastoma, chondromyxoid fibroma, and aggressive variants of fibrous dysplasia or simple bone cysts.
* Low-Grade Primary Sarcomas: Low-grade intramedullary chondrosarcoma.
* Metastatic Disease: Solitary or oligometastatic lesions where durable local control is required without the morbidity of wide resection.

Morphologic and Anatomic Criteria

The ideal lesion is periarticular or located in the sacrum, where wide resection would dictate arthrodesis, complex endoprosthetic reconstruction, or profound neurologic deficit. However, the lesion must leave a sufficient circumferential rim of cortical bone post-curettage to act as a physical receptacle for the liquid nitrogen or gel medium, and to provide a structural foundation for subsequent composite reconstruction.

Preoperative Planning and Surgical Anatomy

Preoperative imaging, including orthogonal radiographs, computed tomography (CT) for cortical integrity, and magnetic resonance imaging (MRI) for soft tissue and intra-articular extension, is mandatory.

Preoperative plain radiograph and MRI demonstrating a large, subchondral giant cell tumor of the proximal tibia, an ideal candidate for joint-preserving cryoablation.

Surgical exposure must be meticulously planned. A pneumatic tourniquet is highly recommended to minimize hemorrhage, which can act as a thermal barrier (heat sink) and impede the freezing process.

A generous surgical incision is required to allow for the mobilization of robust fasciocutaneous flaps, ensuring the overlying soft tissues can be retracted safely away from the thermal field.

Detailed Surgical Technique: Direct Pour Cryoablation

The surgical procedure is executed in five distinct phases: tumor exposure, intralesional curettage, high-speed burring, cryoablation, and composite reconstruction.

Cortical Window and Meticulous Curettage

A large cortical window, corresponding to the longest longitudinal dimension of the tumor, is created. To mitigate stress-riser effects and reduce postoperative fracture risk, the window should be distinctly elliptical with its axis parallel to the long axis of the bone. Gross tumor is aggressively removed using hand curettes of varying sizes.

(Note: URL adjusted to match provided list if necessary, using provided URL)

Following gross removal with hand curettes, the cavity undergoes systematic high-speed burring. This step is critical to break down bony ridges and expose microscopic tumor extensions within the cancellous bone.

The Direct Pour Procedure

Prior to introducing liquid nitrogen, any cortical perforations must be meticulously identified and sealed with an absorbable gelatin sponge (e.g., Gelfoam) to prevent inadvertent extravasation of the freezing agent into the soft tissues. The neurovascular bundles and fasciocutaneous flaps are mobilized and physically shielded using surgical laparotomy pads.

Stainless steel funnels are utilized to direct the liquid nitrogen. The surrounding soft tissues are heavily protected and continuously irrigated with warm saline to prevent collateral thermal injury.

Liquid nitrogen is poured directly into the cavity. Thermocouples may be placed in the cavity wall and at a 1- to 2-mm distance from the periphery to monitor the freeze. The active freeze phase (boiling of the liquid nitrogen) is maintained for 1 to 2 minutes, followed by a spontaneous thaw phase lasting 3 to 5 minutes. A complete cycle is achieved when the cavity temperature rises above 0°C. Standard protocol dictates two complete freeze-thaw cycles to maximize tumor cell death.

Direct pour of liquid nitrogen into the tumor cavity. Continuous warm saline irrigation of the periphery is mandatory throughout the 5-minute cycle.

Detailed Surgical Technique: Closed Argon-Based Cryoablation

While the direct pour technique is highly effective, it is gravity-dependent, making it difficult to treat the "roof" of a cavity. Furthermore, fluid dynamics limit precise temperature control. To circumvent these limitations, closed argon-gas cryoablation systems were developed.

Argon Gas Mechanics

This system utilizes the Joule-Thomson effect. The tumor cavity is filled with a conductive, water-soluble gel medium. Specially designed metal probes are inserted into the gel. High-pressure argon gas is circulated through the internal lumen of the probes; as the gas expands at the tip, it rapidly absorbs heat, generating an ice ball that freezes the surrounding gel and bone.

Various sizes of metal probes are available. The gel acts as a conformal conducting medium, allowing the ice ball to adapt to the irregular geometry of the curetted cavity.

Clinical application of the argon system in a proximal tibia GCT. The computer-controlled delivery allows for precise isotherm mapping and eliminates the risk of liquid spillage.

This technique is particularly advantageous for complex geometries, non-dependent cavities, and small bones (e.g., hands and feet) where a funnel cannot be accommodated.

Curettage and burring of a recurrent low-grade chondrosarcoma of the distal radius.

The cavity is filled with gel and ablated. The closed argon system is ideal for small anatomic sites, such as the distal radius or the phalanges/metatarsals, where liquid nitrogen pour is technically prohibitive.

Defect Reconstruction and Biomechanics

Cryoablation renders the host bone temporarily avascular and mechanically incompetent. The necrotic rim acts as a stress riser, making the bone highly susceptible to pathologic fracture. Therefore, robust, rigid composite reconstruction is an absolute requirement.

Composite Cementation and Fixation

The standard of care involves the use of polymethylmethacrylate (PMMA) bone cement combined with rigid internal fixation (plates, screws, or intramedullary nails). PMMA provides immediate structural stability and resists compressive loads, while the hardware neutralizes torsional and bending forces. Additionally, the exothermic reaction of the curing PMMA provides a secondary, albeit mild, thermal adjuvant effect.

To protect the adjacent articular cartilage from the thermal and mechanical properties of the cement, the subchondral bone plate should be reinforced with a layer of autologous or allogeneic cancellous bone graft prior to cementation.

Composite reconstruction utilizing intramedullary implants, PMMA, and subchondral bone grafting. This biomechanical principle must be applied across all anatomic locations to prevent catastrophic structural failure.

Postoperative Care and Rehabilitation Protocols

Given the extent of tissue necrosis and the presence of a large foreign body (PMMA/hardware), patients are at an elevated risk for deep infection. Routine prophylactic intravenous antibiotics are administered for 3 to 5 days postoperatively.

Rehabilitation must respect the compromised biomechanics of the frozen bone. For lower extremity lesions, patients are maintained on strict non-weight-bearing status for a minimum of 6 weeks. Serial radiographs are obtained to monitor for hardware failure, cement subsidence, and the incorporation of the subchondral bone graft. Gradual progression to partial and full weight-bearing is permitted only after radiographic evidence of peripheral bone remodeling and clinical absence of mechanical pain.

Clinical Outcomes and Oncologic Efficacy

The most robust data regarding cryoablation efficacy is derived from the treatment of Giant Cell Tumors of bone. Historically, intralesional curettage alone yielded unacceptable local recurrence rates ranging from 40% to 55%. The addition of high-speed burring and liquid nitrogen cryoablation has dramatically altered the natural history of this disease.

Large institutional series (e.g., Malawer et al.) have reported local recurrence rates dropping to as low as 2.3% for GCTs treated with this multimodality intralesional approach. Because the joint is preserved and the extensor/flexor mechanisms remain largely undisturbed, functional outcomes are rated as good to excellent in over 90% of patients.

Demonstration of full, symmetric knee flexion and extensor mechanism preservation in a patient 3 months post-cryoablation for a lateral femoral condyle chondrosarcoma. Such functional preservation is impossible with distal femoral resection and endoprosthetic replacement.

Similar rates of local control are observed in other benign aggressive lesions and low-grade chondrosarcomas, provided the tumor is entirely intraosseous and lacks massive soft tissue extension.

Complications and Management Strategies

The early historical application of cryoablation was marred by severe complications, stemming from an underappreciation of the profound collateral tissue damage induced by uncontrolled freezing. Modern surgical refinements—specifically soft tissue mobilization, continuous warm saline irrigation, rigid composite fixation, and prolonged postoperative antibiotics—have mitigated, but not eliminated, these risks.

Postoperative Pathologic Fractures

Fractures through the cryoablated bone were historically the most devastating complication, occurring due to early weight-bearing on mechanically incompetent, necrotic bone. These fractures exhibit delayed healing (often 3 to 9 months) due to the lack of local osteogenic potential.

Pathologic fracture and subsequent articular collapse of the proximal tibia following cryoablation. In this historical case, reconstruction was attempted with bone graft alone, lacking the necessary rigid PMMA/hardware composite. This failure ultimately required salvage with a megaprosthesis.

When modern composite fixation is utilized, the fracture rate is minimal. If a fracture does occur around a cemented construct, it is usually minimally displaced and can often be managed non-operatively with prolonged immobilization.

Soft Tissue and Neural Injury

Inadequate mobilization or protection of the fasciocutaneous flaps and neurovascular bundles can lead to full-thickness skin necrosis, deep infection, and neuropraxia.

Severe thermal injury to the soft tissues of the leg due to inadvertent spillage of liquid nitrogen and inadequate warm saline irrigation. This complication highlights the safety advantage of closed argon systems.

Neural injuries (e.g., peroneal nerve palsy during proximal tibia ablation) are typically axonotmetic due to the thermal insult and usually resolve spontaneously over several months, provided the nerve was not physically transected.

Articular Cartilage Degeneration

Despite the close proximity of the freezing agent to the joint space, the articular cartilage demonstrates remarkable resilience to cryoablation, likely due to its avascular nature and the insulating properties of the subchondral bone graft. Clinically significant secondary osteoarthritis occurs in less than 3% of properly selected cases.

Radiographs demonstrating late-onset degenerative changes of the tibial plateau eight years following cryoablation of a massive subchondral giant cell tumor.

Venous Gas Embolism

A rare but potentially fatal complication specific to the open liquid nitrogen pour technique is venous gas embolism. At room temperature, liquid nitrogen rapidly undergoes a phase change to nitrogen gas (N2). The pressure generated by this boiling within a confined, rigid bony cavity can force nitrogen gas into the venous sinusoids of the cancellous bone and subsequently into the pulmonary circulation.

Intraoperatively, this manifests as an acute, unexplained drop in end-tidal CO2 (EtCO2) and oxygen saturation, accompanied by hypotension and tachycardia. Management requires immediate cessation of the procedure, flooding the field with warm saline to halt boiling, discontinuation of nitrous oxide (which expands gas bubbles), administration of 100% oxygen, and standard hemodynamic resuscitative measures.